Rights and permissions
About this article
Cite this article
Drotrecogin alfa a cost-effective choice for severe sepsis. Pharmacoecon. Outcomes News 491, 8 (2005). https://doi.org/10.2165/00151234-200504910-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504910-00016